SIGA Technologies, Inc. (SIGA), a commercial-stage pharmaceutical company, said on Monday that it has appointed Diem Nguyen as Chief Executive Officer with effect from January 27.Nguyen will succeed SIGA's current CEO, Phil Gomez, who will retire on January 26.Nguyen joins SIGA from Xalud Therapeutics, where she served as CEO.Prior to Xalud, she had worked as Executive Vice President of Biopharma at PPD Inc.

商业舞台制药公司SIGA Technologies，Inc.（SIGA）周一表示，已任命Diem Nguyen为首席执行官，自1月27日起生效。Nguyen将接替SIGA现任首席执行官Phil Gomez，Phil Gomez将于1月26日退休。Nguyen从Xalud Therapeutics加入SIGA，她曾在Xalud Therapeutics担任首席执行官。在Xalud之前，她曾在PPD Inc.担任生物制药执行副总裁。

From 2009 to 2018, Nguyen served in several roles at Pfizer, including global president, Americas, and Pfizer Essential Health. For comments and feedback contact: editorial@rttnews.comBusiness News.

从2009年到2018年，阮曾在辉瑞担任多个职位，包括全球总裁，美洲和辉瑞Essential Health。如需评论和反馈，请联系：editorial@rttnews.comBusiness新闻。

Biotech Stocks Facing FDA Decision In November 2023

2023年11月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision In October 2023

2023年10月美国食品和药物管理局（FDA）决定生物技术股

Biotech Stocks Facing FDA Decision in August 2023

2023年8月美国食品和药物管理局（FDA）决定生物技术股